Pharmacokinetics of novel hexapeptides with neurotensin activity in rats. 1993

R Machida, and T Tokumura, and Y Tsuchiya, and A Sasaki, and K Abe
Tsukuba Research Laboratories, Eisai Co., Ltd., Ibaraki, Japan.

A high-performance liquid chromatographic method to determine (Me)Arg-Lys-Pro-Trp-tert-Leu-Leu (NT-2) with neurotensin (NT) activity in rat plasma was developed and a pharmacokinetic study was performed in rats. Quantitative analysis with high reproducibility was achieved for NT-2 over the concentration range of 1.14-500 ng/ml. (Me)Arg-Lys-Pro-Trp-tert-Leu-Leu-OEt (NT-1) was rapidly hydrolyzed to NT-2 in rat plasma at 37 degrees C. This degradation of NT-1 was observed as a pseudo first-order reaction, and the pseudo first-order rate constant was calculated to be 7.26 min-1 (t1/2 = 0.095 min). The pharmacokinetic profiles of NT-2 after intravenous administration of NT-1 at doses of 0.1 and 0.3 mg/kg were compatible with that of NT-2 after intravenous administration of NT-2 at 0.5 mg/kg. Range of the half-life of the terminal phase (t1/2 beta) of NT-2 was 0.36-0.53 h. The absolute bioavailabilities after oral administrations of NT-1 and NT-2 at a dose of 20 mg/kg were 0.61 +/- 0.17 (mean +/- S.E.) and 0.19 +/- 0.08%, respectively. It was found that NT-1 was more suitable for oral administration than NT-2.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007421 Intestine, Small The portion of the GASTROINTESTINAL TRACT between the PYLORUS of the STOMACH and the ILEOCECAL VALVE of the LARGE INTESTINE. It is divisible into three portions: the DUODENUM, the JEJUNUM, and the ILEUM. Small Intestine,Intestines, Small,Small Intestines
D008297 Male Males
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009496 Neurotensin A biologically active tridecapeptide isolated from the hypothalamus. It has been shown to induce hypotension in the rat, to stimulate contraction of guinea pig ileum and rat uterus, and to cause relaxation of rat duodenum. There is also evidence that it acts as both a peripheral and a central nervous system neurotransmitter.
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein

Related Publications

R Machida, and T Tokumura, and Y Tsuchiya, and A Sasaki, and K Abe
February 1989, The Journal of clinical endocrinology and metabolism,
R Machida, and T Tokumura, and Y Tsuchiya, and A Sasaki, and K Abe
April 2012, European journal of medicinal chemistry,
R Machida, and T Tokumura, and Y Tsuchiya, and A Sasaki, and K Abe
January 1989, British journal of pharmacology,
R Machida, and T Tokumura, and Y Tsuchiya, and A Sasaki, and K Abe
September 1984, British journal of pharmacology,
R Machida, and T Tokumura, and Y Tsuchiya, and A Sasaki, and K Abe
January 2003, European journal of pharmacology,
R Machida, and T Tokumura, and Y Tsuchiya, and A Sasaki, and K Abe
August 1989, Arzneimittel-Forschung,
R Machida, and T Tokumura, and Y Tsuchiya, and A Sasaki, and K Abe
August 2019, Chemico-biological interactions,
R Machida, and T Tokumura, and Y Tsuchiya, and A Sasaki, and K Abe
March 2021, Microbial biotechnology,
R Machida, and T Tokumura, and Y Tsuchiya, and A Sasaki, and K Abe
October 2001, European journal of pharmacology,
R Machida, and T Tokumura, and Y Tsuchiya, and A Sasaki, and K Abe
March 1991, The Journal of pharmacology and experimental therapeutics,
Copied contents to your clipboard!